Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

NAMSA and Fortuna Clinical form strategic relationship

September 5, 2015 By MDO Editor

Form Strategic Relationship

NAMSA and Fortuna Clinical have engaged in a strategic partnership to expand their support and expertise in the cardiovascular arena. Photo credit: www.cstoredecisions.com

NAMSA, a global medical research organization, and Fortuna Clinical, a global medical device clinical research organization, are pleased to announce their strategic relationship. As a result of the increase in demand of NAMSA’s clinical services driven by the development of the MRO Approach, NAMSA and Fortuna Clinical have engaged in a strategic partnership to expand their support and expertise in the cardiovascular arena.

“We are excited to join forces with Dr. Jan Skowronski and Fortuna Clinical so cardiovascular device manufacturers can have the benefit of expert regulatory, laboratory, clinical and medical expertise to cover all facets of patient safety and product efficacy benefits from a single source,” said John Gorski, president and CEO of NAMSA. “Ultimately, this helps accelerate our clients’ product development effort from bench to bedside.”

“Cardiovascular device studies are our passion,” said Jan Skowronski, MD, MBA and CEO of Fortuna Clinical. “In the past I have served as an investigator in multiple device trials and we use our experience and expertise in strengthening NAMSA’s position in cardiovascular clinical trials. We consider Fortuna Clinical to be a CRO ‘with a twist,’ as we believe that the best outcome of a clinical study can only be achieved by close collaboration with the investigators, including assistance with case selection and strong clinical support. In all aspects of medicine, but especially in a setting of a clinical trial, each subject should be treated like our own family member.”

Fortuna Clinical provides NAMSA expertise and access to high growth areas for cardiovascular clinical trial implementation, like Eastern Europe, and will allow for NAMSA to further expand its presence in Western and Central Europe, Asia Pacific and North America. The strategy to join forces with Fortuna continues to reinforce and expand the benefits of NAMSA’s MRO offering, reducing the time to market and the cost to launch new medical device products.

“We are thrilled about our partnership with NAMSA, and we are confident that our relationship will position NAMSA as the future market leader in worldwide cardiovascular clinical trials,” said Peter Kopczynski, MBA, COO of Fortuna Clinical.

With this partnership, NAMSA will continue to provide world-class industry leading strategies and services for market approval and market adoption of medical devices for medical device manufacturers. Through its global MRO Approach, thousands of clients worldwide benefit from NAMSA’s combination of regulatory and quality consulting, laboratory testing and clinical services to solve problems, build value and reduce risk.

NAMSA
www.namsa.com

Fortuna Clinical
www.fortunaclinical.com

Related Articles Read More >

A photo of the FDA headquarters in Silver Spring, Maryland.
Survey finds doctors are losing trust in the FDA and CDC
Fort Wayne Metals, Vascotube, Euroflex, Admedes and MeKo MedTech launch PRIME Project for nitinol supply chain strength
The Partner Companies buys electroformed metal manufacturer Precision Eforming
Eurofins Medical Device Services names North American head of regulatory toxicology
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe